DC
ACLX

Decheng Capital’s Arcellx ACLX Stock Holding History

Decheng Capital’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-547,609
Closed -$4.46M – 24
2025
Q2 		$4.46M Buy
547,609
+497,609
+995% +$31M 1.13% 13
2025
Q1 		$3.28M Sell
50,000
-34,377
-41% -$2.33M 0.92% 17
2024
Q4 		$6.47M Buy
84,377
+63,200
+298% +$5.46M 1.39% 15
2024
Q3 		$1.77M Buy
21,177
+20,000
+1,699% +$1.33M 0.42% 21
2024
Q2 		$65K Buy
+1,177
New +$64K 0.02% 24

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return